Cubist Systematic Strategies, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 4,400 shares of REGN stock, worth $3.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,400
Holding current value
$3.09 Million
% of portfolio
0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $15.6 Million - $17.7 Million
20,065 Added 740.95%
22,773 $20 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $3.4 Million - $4.15 Million
-4,911 Reduced 64.46%
2,708 $2.23 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $10.4 Million - $12.3 Million
-14,871 Reduced 66.12%
7,619 $5.47 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $13.7 Million - $16.6 Million
20,126 Added 851.35%
22,490 $18.5 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $470,122 - $510,415
666 Added 39.22%
2,364 $1.71 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $5.18 Million - $6.54 Million
-9,027 Reduced 84.17%
1,698 $1.17 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $5.83 Million - $7.85 Million
10,625 Added 10625.0%
10,725 $6.34 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $5.47 Million - $6.42 Million
-9,188 Reduced 98.92%
100 $70,000
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $4.13 Million - $5.1 Million
-7,594 Reduced 44.98%
9,288 $5.87 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $5.81 Million - $6.9 Million
10,129 Added 149.99%
16,882 $10.2 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $3.6 Million - $4.25 Million
-7,611 Reduced 52.99%
6,753 $3.77 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $4.56 Million - $5.59 Million
10,206 Added 245.45%
14,364 $6.8 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $421,382 - $535,630
-881 Reduced 17.48%
4,158 $2.01 Million
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $2.78 Million - $3.35 Million
-5,095 Reduced 50.28%
5,039 $2.82 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $2.09 Million - $2.73 Million
4,235 Added 71.79%
10,134 $6.32 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $5.35 Million - $7.86 Million
-15,907 Reduced 72.95%
5,899 $2.88 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $3.2 Million - $4.39 Million
11,665 Added 115.03%
21,806 $8.19 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $3.38 Million - $3.94 Million
-12,366 Reduced 54.94%
10,141 $2.81 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $4.78 Million - $6.61 Million
15,941 Added 242.78%
22,507 $7.05 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $1.98 Million - $2.33 Million
5,312 Added 423.6%
6,566 $2.7 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $3.17 Million - $3.81 Million
-9,446 Reduced 88.28%
1,254 $468,000
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $3.65 Million - $4.25 Million
10,400 Added 3466.67%
10,700 $4.32 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $551,270 - $668,245
-1,937 Reduced 86.59%
300 $103,000
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $2.94 Million - $3.66 Million
-9,303 Reduced 80.62%
2,237 $770,000
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $3.93 Million - $5.15 Million
10,965 Added 1906.96%
11,540 $4.34 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $248,043 - $289,800
575
575 $257,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email